NCRI is ideally placed to support Partners and researchers to capitalise on advances in our understanding of tumour biology and new technologies to develop high-quality research studies for the prevention and early diagnosis of cancer.

This new NCRI Prevention and Early Diagnosis Group, evolved from the previous Screening, Prevention and Early Diagnosis Advisory Group, will have strategic oversight of UK cancer (screening) prevention and early diagnosis research and the development of new research proposals.

The cross-cutting group was identified as well-suited for the activities in this area and will work with other site-specific NCRI Groups. Key activities for the group will include the identification of research gaps, the development of new research, supporting researchers to develop fundable research proposals and developing links with the wider cancer research community.